T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections

Twenty‐nine patients with chronic hepatitis C and 15 asymptomatic hepatitis C virus antibody–positive subjects who clinically recovered from hepatitis C virus infection were studied for their peripheral blood lymphomononuclear cell proliferative response to hepatitis C virus structural and nonstructural antigens (core, envelope, nonstructural 4 and nonstructural 5) expressed in yeast as superoxide dismutase fusion proteins, in an initial attempt to define some of the features of the virus‐specific immune response. Hepatitis C virus core was the most immunogenic antigen for human leukocyte antigen class II–restricted T cells in both groups of patients studied, and the proliferative response to it was the most vigorous and the most frequently expressed in comparison with the other antigens tested. The specificity of the results was supported by the lack of response to hepatitis C virus antigens by healthy uninfected controls and confirmed by recognition of recombinant core proteins of different origin (yeast and baculovirus) by polyclonal T‐cell lines produced by T‐cell stimulation with yeast‐derived core. Each of the antigens tested was able to induce significant although variable levels of proliferative response, indicating that all can be immunogenic at the T‐cell level. Significant proliferative responses to core, nonstructural 4 and nonstructural 5 antigens were more frequently detected in subjects who were able to eradicate infection than in patients with chronic hepatitis C, although the difference was statistically not significant. No difference was observed between the two groups of patients with respect to the response to the putative envelope antigens. (Hepatology 1994;19:286–295).

[1]  C. Ferrari,et al.  Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease. , 2008, Liver.

[2]  M. Houghton,et al.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection. , 1993, Gastroenterology.

[3]  B. Walker,et al.  Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.

[4]  M. Puoti,et al.  Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection , 1992, Hepatology.

[5]  R. Ahmed,et al.  Immunological memory against viruses. , 1992, Seminars in immunology.

[6]  G. Nemo,et al.  HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .

[7]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[8]  F. Chisari,et al.  Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. , 1991, The Journal of clinical investigation.

[9]  A. Alberti,et al.  Antibody to hepatitis C virus in post-transfusion hepatitis. , 1991, Annals of internal medicine.

[10]  M. Houghton,et al.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay , 1991, The Lancet.

[11]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[12]  H J Alter,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.

[13]  M. Houghton,et al.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[15]  M. Houghton,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 1989, The Lancet.

[16]  D. Sansonno,et al.  ANTIBODIES TO HEPATITIS C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER DISEASE , 1989, The Lancet.

[17]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[18]  M. Houghton,et al.  ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS , 1989, The Lancet.

[19]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[20]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[21]  R. Deitch How Generous Has This Government Really Been to the NHS? , 1984, The Lancet.

[22]  A. Saxon,et al.  Single step separation of human T and B cells using AET treated srbc rosettes. , 1976, Journal of immunological methods.

[23]  Williams Jt,et al.  ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING. , 1964, Lancet.

[24]  S. Lemon,et al.  Viral Hepatitis and Liver Disease , 1994, Springer Japan.

[25]  H. Blum,et al.  Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). , 1990, Journal of hepatology.

[26]  M. Houghton,et al.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.

[27]  G. B. Thornton,et al.  Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site , 1987, Nature.

[28]  C. Taswell Limiting Dilution Assays for the Separation, Characterization, and Quantitation of Biologically Active Particles and Their Clonal Progeny , 1987 .